Roger Strode Featured in Q&A on the Rise of Private Equity Investments in Cardiology
February 15, 2023
Cardiovascular Business
Foley & Lardner LLP Partner Roger Strode is featured in the Cardiovascular Business Q&A “What the rise of private equity investments in cardiology means for cardiologists and their patients.”
Strode explains the trend of recapitalization transactions in the health care space, what makes cardiology so appealing to investors right now, and the long-term strategy of and perspectives on these investments.
People
Related News
June 6, 2025
In the News
David Rosen Comments on FDA, Compounder Conflict Over Drug Shortages
Foley & Lardner LLP partner David Rosen highlighted the U.S. Food and Drug Administration's drug shortage list in the BioSpace article, "Post-Chevron Legal Battles: Three Key Cases to Watch."
June 5, 2025
In the News
Michael Bennett and Zack Flagel Explore Pro Tennis Antitrust Battle
Foley & Lardner LLP attorneys Michael Bennett and Zack Flagel assess the antitrust litigation embroiling professional tennis in their LawInSport article, "Break(ing) Point? The Antitrust Battle that Could Transform Professional Tennis."
June 4, 2025
In the News
Foley Attorneys Explore IP Considerations for AI-Generated Logos
Foley & Lardner LLP attorneys Von Bryant, Norm Rich, and Alex Liederman authored the Bloomberg Law article, "AI-Generated Logos Require Careful Steps to Protect IP Rights."